Madrigal Pharmaceuticals

Olivia
Marketing

Meet Madrigal, which wants to be your liver's No. 1 fan

Madrigal is aiming to accomplish what has so far proven to be impossible: to bring a fatty liver drug across the FDA finish line and onto the market.
Ben Adams Nov 15, 2023 9:40am
liver NASH NAFLD

Madrigal, eyeing a NASH drug launch, nabs Dupixent vet as CCO

Nov 13, 2023 9:30am
FDA stop sign

UPDATED: Intercept restructures as NASH hopes dashed by FDA

Jun 22, 2023 6:20pm
FDA conference hall

FDA calls AdComm for Intercept's NASH drug application

Mar 10, 2023 11:18am
NASH

Madrigal's NASH candidate tops Intercept rival in ICER study

Feb 17, 2023 11:23am